Repligen(RGEN) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Repligen Corporation 41 Seyon Street Building #1, Suite 100 Waltham, Massachusetts 02453 Repligen Reports Third Quarter 2024 Financial Results • Third quarter reported revenue of $155 million, an increase of 10% year-over-year • CDMO revenue and orders both up ~20% year-over-year • Overall order intake outpaced sales by 4% • Full year revenue guidance narrowed to range of $630-$639 million WALTHAM, Mass., November 12, 2024 — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on ...